SY07-4 History and future of oncology early phase global clinical development in Asia

Abstract

First-in-human (FIH) clinical trials in oncology are highly complex and can only be conducted at a globally small number of highly specialized and qualified hospitals. Historically, early clinical data on new drugs oftentimes had to be generated in national trials, conducted after the global FIH trial. This led to unnecessary delays in getting access to new innovative drugs for patients in Asian countries.